US 11,896,576 B2
Determination of personalized endocannabinoid genotypes and associated recommendations
Len May, Studio City, CA (US); and Eric Kaufman, Sherman Oaks, CA (US)
Assigned to Endocanna Health, Inc., Burbank, CA (US)
Filed by ENDOCANNA HEALTH, INC., Burbank, CA (US)
Filed on Mar. 27, 2023, as Appl. No. 18/190,778.
Application 18/190,778 is a continuation of application No. 16/760,155, granted, now 11,612,582, previously published as PCT/US2018/058168, filed on Oct. 30, 2018.
Claims priority of provisional application 62/721,294, filed on Aug. 22, 2018.
Claims priority of provisional application 62/680,885, filed on Jun. 5, 2018.
Claims priority of provisional application 62/707,300, filed on Oct. 30, 2017.
Prior Publication US 2023/0293481 A1, Sep. 21, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 15/00 (2018.01); G16H 50/70 (2018.01); G16H 50/20 (2018.01); G16H 70/40 (2018.01); G16H 20/10 (2018.01); G16B 20/20 (2019.01); A61K 31/352 (2006.01); A61K 31/015 (2006.01); A61K 31/05 (2006.01); G06F 3/0484 (2022.01); A61K 45/06 (2006.01)
CPC A61K 31/352 (2013.01) [A61K 31/015 (2013.01); A61K 31/05 (2013.01); G06F 3/0484 (2013.01); G16B 20/20 (2019.02); G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 15/00 (2018.01); G16H 20/10 (2018.01); G16H 50/20 (2018.01); G16H 50/70 (2018.01); G16H 70/40 (2018.01); A61K 45/06 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A computing device comprising:
at least one processor;
a non-transitory computer-readable medium; and
program instructions stored on the non-transitory computer-readable medium that are executable by the at least one processor such that the computing device is configured to:
receive deoxyribonucleic acid (DNA) information associated with a user, wherein the received DNA information is in a first raw DNA data format;
parse the DNA information to identify nucleotide information that is indicative of interactions with cannabinoid formulations;
extract the identified nucleotide information from the DNA information in the first raw DNA data format;
store the extracted nucleotide information in a second parsed DNA data format;
determine, based on the extracted nucleotide information, an endocannabinoid genotype of the user;
access a database identifying (i) a plurality of endocannabinoid genotypes and (ii) a plurality of cannabinoid formulations, wherein each endocannabinoid genotype of the plurality of endocannabinoid genotypes is associated with one or more cannabinoid formulations of the plurality of cannabinoid formulations;
determine a recommendation of a particular cannabinoid formulation of the plurality of cannabinoid formulations based on the particular cannabinoid formulation being associated in the database with the determined endocannabinoid genotype of the user; and
transmit data indicating the recommendation of the particular cannabinoid formulation of the plurality of cannabinoid formulations.